Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Cancer Journal (Sudbury, Mass.)|September 18, 2020
The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant TrialsLandon C Brown, Tian Zhang, Daniel J GeorgeProstate Cancer and Prostatic Diseases|June 3, 2018
Can RECIST response predict success in phase 3 trials in men with metastatic castration-resistant prostate cancer?Landon C Brown, Guru Sonpavde, Andrew J ArmstrongBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 13, 2020
The Immunotherapy Landscape in Renal Cell CarcinomaLandon C Brown, Kunal Desai, Tian Zhang, et al.Prostate Cancer and Prostatic Diseases|March 7, 2020
Androgen receptor variant-driven prostate cancer II: advances in laboratory investigationsChangxue Lu, Landon C Brown, Emmanuel S Antonarakis, et al.Prostate Cancer and Prostatic Diseases|February 26, 2020
Androgen receptor variant-driven prostate cancer II: advances in clinical investigationLandon C Brown, Changxue Lu, Emmanuel S Antonarakis, et al.American Journal of Nephrology|March 20, 2017
The Evolving Role of Rituximab in Adult Minimal Change GlomerulopathyLandon C Brown, Meghan A Jobson, Fernanda Payan Schober, et al.JCO Precision Oncology|December 7, 2023
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate CancerLandon C Brown, Jason Zhu, Elizabeth Mauer, et al.Journal for Immunotherapy of Cancer|September 14, 2021
Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumabLandon C Brown, Kunal Desai, Wei Wei, et al.European Urology Open Science|November 21, 2025
Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA TrialLandon C Brown, Danielle Boselli, James T Symanowski, et al.Translational Andrology and Urology|March 14, 2023
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancerJason Zhu, Chad Livasy, Erin E Donahue, et al.Pageof 3